Wedge Capital Management L L P NC Has $33.20 Million Stake in DaVita Inc. (NYSE:DVA)

Wedge Capital Management L L P NC lessened its stake in shares of DaVita Inc. (NYSE:DVA - Free Report) by 6.9% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 222,007 shares of the company's stock after selling 16,487 shares during the period. Wedge Capital Management L L P NC owned about 0.27% of DaVita worth $33,201,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of DVA. Transcendent Capital Group LLC acquired a new stake in DaVita during the 3rd quarter worth about $25,000. Blue Trust Inc. increased its holdings in shares of DaVita by 56.4% in the 3rd quarter. Blue Trust Inc. now owns 330 shares of the company's stock valued at $54,000 after purchasing an additional 119 shares during the period. Quarry LP acquired a new position in shares of DaVita in the 3rd quarter valued at about $60,000. Point72 Hong Kong Ltd acquired a new position in shares of DaVita in the 2nd quarter valued at about $68,000. Finally, Versant Capital Management Inc increased its holdings in shares of DaVita by 58.7% in the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company's stock valued at $68,000 after purchasing an additional 169 shares during the period. Institutional investors and hedge funds own 90.12% of the company's stock.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on DVA. Truist Financial upped their target price on DaVita from $165.00 to $175.00 and gave the company a "hold" rating in a report on Monday, October 7th. Barclays upped their target price on DaVita from $150.00 to $164.00 and gave the company an "equal weight" rating in a report on Thursday, October 31st. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have issued a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of "Hold" and an average price target of $161.80.

DaVita Stock Up 0.9 %

Shares of NYSE DVA traded up $1.43 during trading hours on Friday, hitting $166.28. The stock had a trading volume of 429,777 shares, compared to its average volume of 606,593. The company has a market capitalization of $13.63 billion, a P/E ratio of 17.94, a P/E/G ratio of 0.75 and a beta of 0.92. The firm's 50-day moving average price is $157.11 and its two-hundred day moving average price is $152.71. DaVita Inc. has a 52 week low of $103.40 and a 52 week high of $169.51. The company has a debt-to-equity ratio of 15.78, a quick ratio of 1.33 and a current ratio of 1.37.

DaVita (NYSE:DVA - Get Free Report) last announced its earnings results on Tuesday, October 29th. The company reported $2.59 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $2.76 by ($0.17). The company had revenue of $3.26 billion for the quarter, compared to the consensus estimate of $3.25 billion. DaVita had a return on equity of 88.18% and a net margin of 6.53%. The firm's revenue for the quarter was up 4.6% compared to the same quarter last year. During the same period in the previous year, the company earned $2.85 EPS. Analysts anticipate that DaVita Inc. will post 9.71 EPS for the current fiscal year.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.